[1] CHAIMOVITZ C.Peritoneal dialysis[J].Kidney Int,1994,45(4):1226-1240.
[2] DEVUYST O,MARGETTS P J,TOPLEY N.The pathophysiology of the peritoneal membrane[J].J Am Soc Nephrol,2010,21(7):1077.
[3] TOMINO Y.Mechanisms and interventions in peritoneal fibrosis[J].Clin Exp Nephrol,2012,16(1):109-114.
[4] GAROSI G,CAPPELLETTI F,DI P N.Fibrosis and sclerosis:different disorders or different stages?[J].Contrib Nephrol,2006,150(1):62-69.
[5] HUNG K Y,HUANG J W,TSAI T J,et al.Peritoneal fibrosing syndrome:pathogenetic mechanism and current therapeutic strategies[J].J Chin Med Assoc,2005,68(9):401-405.
[6] PADWAL M,MARGETTS P J.Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis[J].Kidney Res Clin Practice,2016,35(3):133-141.
[7] LAMOUILLE S,XU J,DERYNCK R.Molecular mechanisms of epithelial-mesenchymal transition[J].Nat Rev Mol Cell Biol,2014,15(3):178-196.
[8] PÉREZLOZANO M L,SANDOVAL P,RYNNEVIDAL A,et al.Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition[J].Plos One,2013,8(4):e60776.
[9] COOKER L A,LUNEBURG P,HOLMES C J,et al.Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions[J].Perit Dial Int,2001,21(Suppl 3):S102.
[10] CHO Y,JOHNSON D W,VESEY D A,et al.Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients[J].BMC Nephrol,2014,15(1):1-9.
[11] RODRIGUES-DÍEZ R,AROEIRA L S,OREJUDO M,et al.IL-17A is a novel player in dialysis-induced peritoneal damage[J].Kidney Int,2014,86(2):303-315.
[12] FIELDING C A,JONES G W,MCLOUGHLIN R M,et al.Interleukin-6 signaling drives fibrosis in unresolved inflammation[J].Immunity,2014,40(1):40-50.
[13] DANIEL K,JOERG L,CHRISTOPH U,et al.Activation of nuclear factor of activated T cells 5 in the peritoneal membrane of uremic patients[J].Am J Physiol Renal Physiol,2015,308(11):1247-1258.
[14] BELLÓN T,MARTÍNEZ V,LUCENDO B,et al.Alternative activation of macrophages in human peritoneum:implications for peritoneal fibrosis[J].Nephrol Dial Transplant,2011,26(9):2995-3005.
[15] SUN H L,KANG H Y,KIM K S,et al.The monocyte chemoattractant protein-1(MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelialcells[J].Lab Invest,2012,92(12):1698-1711.
[16] NAIKI Y,MAEDA Y,MATSUO K,et al.Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis[J].Nephrol,2003,16(1):95-102.
[17] SÁNCHEZ-TILLÓE,LIU Y,BARRIOS O D,et al.EMT-activating transcription factors in cancer:Beyond EMT and tumor invasiveness[J].Cell Mol Life Sci Cmls,2012,69(20):3429-3456.
[18] YANG A H,CHEN J Y,LIN J K.Myofibroblastic conversion of mesothelialcells[J].Kidney Int,2003,63(4):1530-1539.
[19] MARGETTS P J,BONNIAUD P,LIU L,et al.Transient overexpression of TGF-beta1 induces epithelial mesenchymal transition in the rodent peritoneum[J].J Am Soc Nephrol,2005,16(2):425-436.
[20] CARTHY,JONATHON M.TGF-β signalling and the control of myofibroblast differentiation:Implications for chronic inflammatory disorders[J].J Cell Physiol,2017,10.1002.
[21] ZHANG,Y.E.Non-Smad Signaling Pathways of the TGF-beta Family[J].Cold Spring Harb PerspectBiol,2017,9:a022129.
[22] JANG Y H,SHIN H S,SUN C H,et al.Effects of dexamethasone on the TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells[J].Lab Invest,2013,93(2):194-206.
[23] STRIPPOLI R,MORENO-VICENTE R,BATTISTELLI C,et al.Molecular mechanisms underlying peritoneal EMT and fibrosis[J].Stem Cell Int,2016,2016:3543678.
[24] DERYNCK R,ZHANG YE.Smad-dependent and Smad-independent pathways in TGF-beta family signalling.[J].Nature,2003,425(6958):577-584.
[25] YAO Q,PAWLACZYK K,AYALA E R,et al.The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions[J].Nephron Exp Nephrol,2008,109(2):e71-78.
[26] BIERNACK A,DOBACZEWSK I M,FRANGOGIANNI SN G.TGF-β signaling in fibrosis[J].Growth Factors,2011,29(5):196-202.
[27] DUAN W J,YU X,HUANG X R,et al.Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro[J].Am J Pathol,2014,184(8):2275-2284.
[28] LIU G X,LI Y Q,HUANG X R,et al.Disruption of Smad7 promotes ANG Ⅱ-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice[J].Plos One,2013,8(1):e53573.
[29] SUN Y,ZHU F,YU X,et al.Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis[J].Am J Nephrol,2009,30(1):84-94.
[30] WEISHENG P,XIANRUI D,WENKE H,et al.Smad7 gene transfer attenuates angiogenesis in peritoneal dialysis rats[J].Nephrology,2013,18(2):138-147.
[31] WANG X,LI X,YE L,et al.Smad7 inhibits TGF-β1-induced MCP-1 upregulation through a MAPK/p38 pathway in rat peritoneal mesothelial cells[J].Int Urol Nephrol,2013,45(3):899-907.
[32] MATSUO H,TAMURA M,KABASHIMA N,et al.Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells[J].Kidney Int,2006,69(4):736-746.
[33] HA H,YU M R,LEE H B.High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells[J].Kidney Int,2001,59(2):463-470.
[34] PATEL P,SEKIGUCHI Y,OH K H,et al.Smad3-dependent and-independent pathways are involved in peritoneal membrane injury[J].Kidney Int,2010,77(4):319-328.
[35] LIU Q,ZHANG Y,MAO H,et al.A crosstalk between the Smad and JNK signaling in the TGF-β-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells[J].Plos One,2012,7(2):e32009.
[36] ZHU F,LI T,QIU F,et al.Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats[J].Am J Pathol,2010,176(2):650-659.
[37] YANG J,ZHU T,LIU X,et al.Heat shock protein 70 protects rat peritoneal mesothelial cells from advanced glycation end-products-induced epithelial-to-mesenchymal transition through mitogen activated protein kinases/extracellular signal-regulated kinases and transforming growth fator[J].Mol Med Report,2015,11(6):4473.
[38] LI S,ZHOU Y,FAN J,et al.Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide-induced peritonitis in rats[J].Am J Pathol,2011,179(6):2822-2834.
[39] KALLURI R,NEILSON E G.Epithelial-mesenchymal transition and its implications for fibrosis[J].J Clin Inves,2003,112(12):1776-1784.
[40] YU M A,SHIN K S,KIM J H,et al.HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium[J].J Am Soc Nephrol,2009,20(3):567-581.
[41] ZHOU Q,YANG M,LAN H,et al.miR-30a Negatively regulates TGF-β1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting snai1[J].Am J Pathol,2013,183(3):808-819.
[42] YANG C,ZHENG S D,WU H J,et al.Regulatory mechanisms of the molecular pathways in fibrosis induced by microRNAs[J].Chin Med J,2016,129(19):2365-2372.
[43] MORINELLI T A,LUTTRELL L M,STRUNGS E G,et al.Angiotensin Ⅱ receptors and peritoneal dialysis-induced peritoneal fibrosis[J].Int J Biochem Cell Biol,2016,77(Pt B):240-250.
[44] WANG L,LIU N,XIONG C,et al.Inhibition of EGF receptor blocks the development and progression of peritoneal fibrosis[J].J Am Soc Nephrol,2015:ASN.2015030299.
[45] WU J,LI X,ZHU G,et al.The role of Resveratrol-induced mitophagy/autophagy in peritoneal mesothelial cells inflammatory injury via NLRP3 inflammasome activation triggered by mitochondrial ROS[J].Exp Cell Res,2016,341(1):42-53. |
